Stroke prevention for non-valvular atrial fibrillation: how to make the right choice of directly acting oral anticoagulants?
Patients with atrial fibrillation have a high risk of developing stroke and death, which requires constant anticoagulant support. In this regard, the physician faces the difficult task of selecting the appropriate oral anticoagulant for patient with individual risk factors and comorbidities. Current...
Main Authors: | N. N. Kryukov, E. V. Sayutina, A. M. Osadchuk, M. A. Osadchuk |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2019-02-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2875 |
Similar Items
-
The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis
by: Sohil Elfar, et al.
Published: (2024-01-01) -
Current strategies of anticoagulation therapy for patients with non-valvular atrial fibrillation
by: Masahiro Yasaka
Published: (2012-12-01) -
Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease
by: Alexandros Briasoulis, et al.
Published: (2018-04-01) -
Comparison of the Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Yasmin de Souza Lima Bitar, et al.
Published: (2021-09-01) -
Anticoagulation Therapy for Non-valvular Atrial Fibrillation: A Mini-Review
by: Jia Wu, et al.
Published: (2020-07-01)